D. Raffa et al. / Il Farmaco 54 (1999) 90–94
93
Table 3
Physical and spectroscopic data for compounds 2b,c, 3a–c, 6a–c, 7a–c, 8a–c and 9a–c
Com-
M.p. (°)a
Formula
Yield (%)
IR (Nujol) (cm−1
)
1H NMR (l)b
pound
2b
2c
3a
187–188
225–226
146-149
C11H7N4O2Cl 85
C11H7N4O2Cl 88
1710 (CO)
1700 (CO)
2.44 (s, 3H, CH3); 6.67 (s, 1H, isoxazole H-4); 7.78–8.41 (a set
of signals, 3H, aromatic protons).
2.42 (s, 3H, CH3); 6.65 (s, 1H, isoxazole H-4); 7.95–8.38 (a set
of signals, 3H, aromatic protons).
2.14 (s, 3H, CH3); 6.37 (s, 1H, isoxazole H-4); 7.16–7.91 (a set
of signals, 4H, aromatic protons); 9.51 (s, 1H, exchangeable
NH).
C11H9N2O2I
33
3320–3040 (NH);
1680 (CO)
3b
3c
6a
6b
6c
7a
7b
7c
157–159
181–183
177–179
214–216
162–163
188–189
202–203
198–200
C11H8N2O2ClI 20
C11H8N2O2ClI 39
3310–3100 (NH);
1680 (CO)
2.19 (s, 3H, CH3); 6.37 (s, 1H, isoxazole H-4); 7.38–7.88 (a set
of signals, 4H, aromatic protons); 9.54 (s, 1H, exchangeable
NH).
2.21 (s, 3H, CH3); 6.38 (s, 1H, isoxazole H-4); 7.12–7.83 (a set
of signals, 3H, aromatic protons); 9.38 (s, 1H, exchangeable
NH).
2.42 (s, 3H, CH3); 6.74 (s, 1H, isoxazole H-4); 7.77–8.18 (a set
of signals, 4H, aromatic protons); 11.66 (s, 1H, exchangeable
NH).
2.42 (s, 3H, CH3); 6.74 (s, 1H, isoxazole H-4); 7.80–8.26 (a set
of signals, 3H, aromatic protons); 11.73 (s, 1H, exchangeable
NH).
3320–3100 (NH);
1680 (CO)
C11H9N3O4
43
3300–3020 (NH);
1695 (CO)
C11H8N3O4Cl 53
C11H8N3O4Cl 70
3400–3010 (NH);
1680–1670 (CO)
3300–3000 (NH);
1695 (CO)
2.43 (s, 3H, CH3); 6.74 (s, 1H, isoxazole H-4); 7.82–8.22 (a set
of signals, 3H, aromatic protons); 11.73 (s, 1H, exchangeable
NH).
C11H11N3O2
90
3480–3040 (NH and 2.40 (s, 3H, CH3); 6.55–7.77 (a set of signal, 7H, aromatic
NH2); 1665 (CO)
protons, isoxazole H-4, exchangeable NH2); 10.92 (s, 1H, ex-
changeable NH).
C11H10N3O2Cl 90
C11H10N3O2Cl 60
3500–3020 (NH and 2.40 (s, 3H, CH3); 6.53–7.75 (a set of signal, 6H, aromatic
NH2); 1680 (CO)
protons, isoxazole H-4, exchangeable NH2); 10.99 (s, 1H, ex-
changeable NH).
3500–3020 (NH and 2.40 (s, 3H, CH3); 6.68–7.82 (a set of signal, 6H, aromatic
NH2); 1680 (CO)
1720–1700 (CO)
1710 (CO)
protons, isoxazole H-4, exchangeable NH2); 11.07 (s, 1H, ex-
changeable NH).
2.56 (s, 3H, CH3); 6.63 (s, 1H, isoxazole H-4); 7.86–8.45 (a set
of signals, 4H, aromatic protons).
2.56 (s, 3H, CH3); 6.60 (s, 1H, isoxazole H-4); 7.81–8.40 (a set
of signals, 3H, aromatic protons).
2.56 (s, 3H, CH3); 6.08 (s, 1H, isoxazole H-4); 7.96–8.65 (a set
of signals, 3H, aromatic protons).
8a
8b
8c
9a
173–174
202–203
208–209
147–148
C11H8N4O2
70
C11H7N4O2Cl 65
C11H7N4O2Cl 44
1700 (CO)
C
11H9N2O2I
43
3220–3100 (NH);
1685–1675 (CO)
2.35 (s, 3H, CH3); 6.88 (s, 1H, isoxazole H-4); 7.16–7.93 (a set
of signals, 4H, aromatic protons); 10.17 (s, 1H, exchangeable
NH).
9b
9c
170–172
178–179
C11H7N4O2ClI 50
C11H7N4O2ClI 61
3300–3100 (NH);
1705 (CO)
2.37 (s, 3H, CH3); 6.86 (s, 1H, isoxazole H-4); 7.43–7.93 (a set
of signals, 3H, aromatic protons); 10.33 (s, 1H, exchangeable
NH).
2.38 (s, 3H, CH3); 6.89 (s, 1H, isoxazole H-4); 7.15–7.86 (a set
of signals, 3H, aromatic protons); 10.90 (s, 1H, exchangeable
NH).
3300–3100 (NH);
1705 (CO)
a Crystallization solvent: ethanol.
b CDCl3 for compounds 2b,c, 3a–c, 8a–c, and 9a–c. DMSO-d6 for compounds 6a–c and 7 a–c.
4.1.5. 3-(5-Methylisoxazol-3-yl)-1,2,3-benzotriazin-
4(3H)-ones 8a–c and N-(5-methylisoxazol-3-yl)-2-
iodobenzamides 9a–c
All these compounds were synthesized by the same
procedure previously employed for 2b,c and 3a–c, re-
spectively (see Table 3).
After this time, 500 ml of water were added and the
precipitate which separated out was collected, air
driedand crystallized from ethanol to give 3. Com-
pounds 3a–c are listed in Table 3.
4.1.4. N-(5-Methylisoxazol-3-yl)-2-nitrobenzamides
6a–c and N-(5-methylisoxazol-3-yl)-2-aminobenza-
mides 7a–c
4.2. Biology
Compounds 6 and 7 were obtained by preparative
methods previously reported [13] (see Table 3).
The in vitro antifungal activity against isolates of
plant pathogenic fungi was evaluated by an agar dilu-